Amendment: SEC Form SCHEDULE 13G/A filed by Kestra Medical Technologies Ltd.
$KMTS
Medical/Dental Instruments
Health Care
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)
|
Kestra Medical Technologies, Ltd. (Name of Issuer) |
Common Shares, par value $1.00 per share (Title of Class of Securities) |
G52441105 (CUSIP Number) |
12/31/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | G52441105 |
| 1 | Names of Reporting Persons
Endeavour Medtech Growth II LP | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
GUERNSEY
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,448,942.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
4.20 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
Comment for Type of Reporting Person:
The percent of class is calculated based upon 58,349,053 Common Shares outstanding as of December 5, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed on December 11, 2025, with the Securities and Exchange Commission (the "Form 10-Q").
SCHEDULE 13G
|
| CUSIP No. | G52441105 |
| 1 | Names of Reporting Persons
Endeavour Medtech Growth II Parallel LP | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
GUERNSEY
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,448,942.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
4.20 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
Comment for Type of Reporting Person:
The percent of class is calculated based upon 58,349,053 Common Shares outstanding as of December 5, 2025, as reported in the Form 10-Q.
SCHEDULE 13G
|
| CUSIP No. | G52441105 |
| 1 | Names of Reporting Persons
Endeavour Medtech II GP Limited | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
GUERNSEY
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,448,942.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
4.20 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
CO |
Comment for Type of Reporting Person:
The percent of class is calculated based upon 58,349,053 Common Shares outstanding as of December 5, 2025, as reported in the Form 10-Q.
SCHEDULE 13G
|
| Item 1. | |
| (a) | Name of issuer:
Kestra Medical Technologies, Ltd. |
| (b) | Address of issuer's principal executive offices:
3933 Lake Washington BLVD NE, Suite 200, Kirkland, WA 98003 |
| Item 2. | |
| (a) | Name of person filing:
This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"):
(i) Endeavour Medtech Growth II LP
(ii) Endeavour Medtech Growth II Parallel LP
(iii) Endeavour Medtech II GP Limited
|
| (b) | Address or principal business office or, if none, residence:
The address and principal business address of each of the Reporting Persons is P.O. Box 656, East Wing Trafalgar Court, Les Banques, St. Peter Port, Guernsey GY1 3PP. |
| (c) | Citizenship:
Endeavour Medtech Growth II LP is a Guernsey limited partnership. Endeavour Medtech Growth II Parallel LP is a Guernsey limited partnership. Endeavour Medtech II GP Limited is a Guernsey company limited by shares. |
| (d) | Title of class of securities:
Common Shares, par value $1.00 per share |
| (e) | CUSIP No.:
G52441105 |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
2,405,643 Common Shares are held of record by Endeavour Medtech Growth II LP and 43,299 Common Shares are held of record by Endeavour Medtech Growth II Parallel LP. Endeavour Medtech II GP Limited is the general partner of Endeavour Medtech Growth II LP and Endeavour Medtech Growth II Parallel LP. As a result of foregoing, and the relationships described in Item 2(a) of this Schedule 13G, the Reporting Persons may be deemed to share ownership over the reported 2,448,942 Common Shares, but the filing of this Statement shall not be deemed an admission of such beneficial ownership by any of the Reporting Persons for purposes of Section 13(d) or Section 13(g) or for any other purpose.
|
| (b) | Percent of class:
See responses to Item 11 on each cover page. |
| (c) | Number of shares as to which the person has:
|
| (i) Sole power to vote or to direct the vote:
See responses to Item 5 on each cover page | |
| (ii) Shared power to vote or to direct the vote:
See responses to Item 6 on each cover page. | |
| (iii) Sole power to dispose or to direct the disposition of:
See responses to Item 7 on each cover page. | |
| (iv) Shared power to dispose or to direct the disposition of:
See responses to Item 8 on each cover page. | |
| Item 5. | Ownership of 5 Percent or Less of a Class. |
|
Ownership of 5 percent or less of a class
| |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
Not Applicable
| |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not Applicable
| |
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable
| |
| Item 9. | Notice of Dissolution of Group. |
Not Applicable
|
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
Exhibit Information
|
Exhibit A Joint Filing Agreement, dated as of May 15, 2025, by and among the Reporting persons and filed with the SEC as Exhibit A to the Schedule 13G filed on such date, is hereby incorporated by reference. |